Advertisement
Person › Details
Greg Behar (Recipharm AB)
Behar, Greg (Recipharm 202401– CEO before CEO of Nestlé Health Science before Novartis + Boehringer Ingelheim)
Organisation | Nestlé Health Science S.A. | |
Product | contract manufacturing (biologicals) | |
Record changed: 2023-11-24 |
Advertisement
More documents for Greg Behar
- [1] Recipharm AB. (11/21/23). "Press Release: Marc Funk to Transition to Recipharm's Board of Directors; Greg Behar Appointed New CEO; Inhaled Business to Standalone in 2024"....
- [2] Enterome S.A.. (7/11/17). "Press Release: Enterome and Nestlé Health Sciences Launch New Diagnostics Company". Paris....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top